Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
Titel:
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
Auteur:
Pierceall, W.E. Olaussen, K.A. Rousseau, V. Brambilla, E. Sprott, K.M. Andre, F. Pignon, J.-P. Le Chevalier, T. Pirker, R. Jiang, C. Filipits, M. Chen, Y. Kutok, J.L. Weaver, D.T. Ward, B.E. Soria, J.-C.